Acurx Pharmaceuticals, Inc. ACXP
NASDAQ · United States · Health Technology
$1.260.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.53 | -0.38 | -40.7% | $0 | — | +11.5%$1.48→$1.65 |
| Q1 2026 | 2026-05-11 | -0.62 | -0.59 | -5.1% | — | — | -1.9%$2.09→$2.05 |
| Q4 2025 | 2026-03-12 | -0.31 | -0.99 | +68.7% | — | — | -35.7%$6.03→$3.88 |
| Q3 2025 | 2025-11-12 | -1.23 | -1.61 | +23.6% | — | — | -15.1%$5.58→$4.74 |
| Q2 2025 | 2025-08-11 | -1.89 | -2.10 | +10.0% | — | — | — |
| Q4 2024 | 2025-03-17 | -3.20 | -3.60 | +11.1% | — | — | — |
| Q4 2023 | 2024-03-15 | -7.60 | -4.90 | -55.1% | — | — | — |
| Q3 2023 | 2023-11-13 | -4.80 | -5.00 | +4.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.